Gong L - Search Results

1

A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer.

Cui K, Yao S, Liu B, Sun S, Gong L, Li Q, Fei B, Huang Z. Cui K, et al. Among authors: gong l. Br J Cancer. 2022 Nov;127(8):1450-1460. doi: 10.1038/s41416-022-01936-x. Epub 2022 Aug 8. Br J Cancer. 2022. PMID: 35941174 Free PMC article.

2

Universal endogenous antibody recruiting nanobodies capable of triggering immune effectors for targeted cancer immunotherapy.

Hong H, Li C, Gong L, Wang J, Li D, Shi J, Zhou Z, Huang Z, Wu Z. Hong H, et al. Among authors: gong l. Chem Sci. 2021 Feb 11;12(12):4623-4630. doi: 10.1039/d0sc05332e. Chem Sci. 2021. PMID: 34163726 Free PMC article.

3

Comprehensive Characterization of Integrin Subunit Genes in Human Cancers.

Cui K, Wu X, Gong L, Yao S, Sun S, Liu B, Zhou M, Yin Y, Huang Z. Cui K, et al. Among authors: gong l. Front Oncol. 2021 Jun 16;11:704067. doi: 10.3389/fonc.2021.704067. eCollection 2021. Front Oncol. 2021. PMID: 34222028 Free PMC article.

4

Nanobody-Engineered Natural Killer Cell Conjugates for Solid Tumor Adoptive Immunotherapy.

Gong L, Li Y, Cui K, Chen Y, Hong H, Li J, Li D, Yin Y, Wu Z, Huang Z. Gong L, et al. Small. 2021 Nov;17(45):e2103463. doi: 10.1002/smll.202103463. Epub 2021 Oct 15. Small. 2021. PMID: 34761524

5

SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop.

Bian Z, Zhou M, Cui K, Yang F, Cao Y, Sun S, Liu B, Gong L, Li J, Wang X, Li C, Yao S, Yin Y, Huang S, Fei B, Huang Z. Bian Z, et al. Among authors: gong l. J Exp Clin Cancer Res. 2021 Nov 15;40(1):360. doi: 10.1186/s13046-021-02162-8. J Exp Clin Cancer Res. 2021. PMID: 34782005 Free PMC article.

6

Ferroptosis-Associated Molecular Features to Aid Patient Clinical Prognosis and Therapy Across Human Cancers.

Cui K, Gong L, Wang K, Wang Y, Huang L, Liu B, Li Q, Zhang Q, Fei B, Huang Z. Cui K, et al. Among authors: gong l. Front Immunol. 2022 Jun 20;13:888757. doi: 10.3389/fimmu.2022.888757. eCollection 2022. Front Immunol. 2022. PMID: 35812384 Free PMC article.

7

Chemoenzymatic Synthesis of a Rhamnose-Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy.

Hong H, Lin H, Li D, Gong L, Zhou K, Li Y, Yu H, Zhao K, Shi J, Zhou Z, Huang Z, Wu Z. Hong H, et al. Among authors: gong l. Angew Chem Int Ed Engl. 2022 Sep 19;61(38):e202208773. doi: 10.1002/anie.202208773. Epub 2022 Aug 17. Angew Chem Int Ed Engl. 2022. PMID: 35891606

8

Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204.

Li D, Gong L, Lin H, Yao S, Yin Y, Zhou Z, Shi J, Wu Z, Huang Z. Li D, et al. Among authors: gong l. Cells. 2022 Sep 29;11(19):3065. doi: 10.3390/cells11193065. Cells. 2022. PMID: 36231028 Free PMC article.

9

EXOSC8 promotes colorectal cancer tumorigenesis via regulating ribosome biogenesis-related processes.

Cui K, Gong L, Zhang H, Chen Y, Liu B, Gong Z, Li J, Wang Y, Sun S, Li Y, Zhang Q, Cao Y, Li Q, Fei B, Huang Z. Cui K, et al. Among authors: gong z, gong l. Oncogene. 2022 Dec;41(50):5397-5410. doi: 10.1038/s41388-022-02530-4. Epub 2022 Nov 8. Oncogene. 2022. PMID: 36348012

10

ELOA promotes tumor growth and metastasis by activating RBP1 in gastric cancer.

Tian L, Gong L, Hao C, Feng Y, Yao S, Fei B, Wang X, Huang Z. Tian L, et al. Among authors: gong l. Cancer Med. 2023 Sep;12(18):18946-18959. doi: 10.1002/cam4.6516. Epub 2023 Sep 11. Cancer Med. 2023. PMID: 37694492 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,180 results

Search Page

Filters